{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:33:16Z","timestamp":1793403196105,"version":"4.5.0"},"reference-count":198,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>\n                    NMDA receptors (NMDARs) are widely distributed throughout the central nervous system (CNS) and play pivotal roles in normal physiological processes such as synaptic plasticity, learning, and memory. Substantial evidence indicates that NMDAR dysfunction, particularly excessive calcium influx, critically contributes to the pathogenesis of major neurodegenerative diseases, including Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), Huntington\u2019s disease (HD), and amyotrophic lateral sclerosis (ALS). Dysregulated glutamatergic signaling synergizes with pathological protein aggregation (e.g., A\u03b2,\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -synuclein, mutant huntingtin) to drive neuronal loss. We systematically delineate NMDAR-related mechanisms underlying neurodegeneration, highlighting spatial-specific roles (e.g., synaptic NMDAR-mediated neuroprotection versus extrasynaptic NMDAR-mediated excitotoxicity) and crosstalk with mitochondrial dysfunction and oxidative stress. We critically evaluate current therapeutic strategies targeting NMDARs, including subunit-selective modulators, downstream effector modulation, and glutamate transporter modulation designed to restore NMDAR homeostasis. Consequently, NMDARs and their modulators represent promising therapeutic targets for these refractory conditions. This review comprehensively summarizes current research on the involvement of NMDARs and the glutamatergic system in neurodegenerative diseases. Furthermore, we discuss the clinical application of NMDAR-targeting agents and explore emerging therapeutic strategies focused on modulating NMDAR-related pathways. This article aims to provide a reference for elucidating the molecular mechanisms underlying these neurodegenerative disorders and to highlight potential avenues for future drug development.\n                  <\/jats:p>","DOI":"10.3389\/fnagi.2025.1604378","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T05:33:15Z","timestamp":1753335195000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["NMDA receptors in neurodegenerative diseases: mechanisms and emerging therapeutic strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Keyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaizhu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houze","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1471-4159.1995.65041899.x","article-title":"Enhancement of beta-amyloid peptide a beta(1-40)-mediated neurotoxicity by glutamine synthetase","volume":"65","author":"Aksenov","year":"1995","journal-title":"J. Neurochem."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"9854","DOI":"10.1126\/sciadv.aba9854","article-title":"Na(+)-dependent gate dynamics and electrostatic attraction ensure substrate coupling in glutamate transporters","volume":"6","author":"Alleva","year":"2020","journal-title":"Sci. Adv."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11064-021-03252-x","article-title":"Molecular basis of coupled transport and anion conduction in excitatory amino acid transporters","volume":"47","author":"Alleva","year":"2022","journal-title":"Neurochem. Res."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"118020","DOI":"10.1016\/j.lfs.2020.118020","article-title":"The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease","volume":"257","author":"Amidfar","year":"2020","journal-title":"Life Sci."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"108719","DOI":"10.1016\/j.neuropharm.2021.108719","article-title":"Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration","volume":"196","author":"Andersen","year":"2021","journal-title":"Neuropharmacology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"174310","DOI":"10.1016\/j.ejphar.2021.174310","article-title":"NMDA and AMPA receptors dysregulation in Alzheimer's disease","volume":"908","author":"Babaei","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20161673","article-title":"Therapeutic targeting of the pathological triad of extrasynaptic NMDA receptor signaling in neurodegenerations","volume":"214","author":"Bading","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrn3677","article-title":"Hippocampal synaptic plasticity, spatial memory and anxiety","volume":"15","author":"Bannerman","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JAD-150650","article-title":"Diminished CRE-induced plasticity is linked to memory deficits in familial Alzheimer's disease mice","volume":"50","author":"Bartolotti","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410380304","article-title":"Aging, energy, and oxidative stress in neurodegenerative diseases","volume":"38","author":"Beal","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1002\/ana.410440716","article-title":"Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis","volume":"44","author":"Beal","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/bph.16235","article-title":"Pharmacological characterization of SAGE-718, a novel positive allosteric modulator of N-methyl-d-aspartate receptors","volume":"181","author":"Beckley","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/mus.28287","article-title":"A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis","volume":"71","author":"Bhai","year":"2025","journal-title":"Muscle Nerve"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/361031a0","article-title":"A synaptic model of memory: long-term potentiation in the hippocampus","volume":"361","author":"Bliss","year":"1993","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2217\/nnm.09.67","article-title":"Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution","volume":"5","author":"Bond\u00ec","year":"2010","journal-title":"Nanomedicine (Lond.)"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1385\/MN:27:3:325","article-title":"Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria","volume":"27","author":"Brown","year":"2003","journal-title":"Mol. Neurobiol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00401-019-01964-7","article-title":"Disrupted neuronal trafficking in amyotrophic lateral sclerosis","volume":"137","author":"Burk","year":"2019","journal-title":"Acta Neuropathol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"RC148","DOI":"10.1523\/JNEUROSCI.21-11-j0002.2001","article-title":"Increased expression of neuronal nitric oxide synthase spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord","volume":"21","author":"Catania","year":"2001","journal-title":"J. Neurosci."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/2105607","article-title":"Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view","volume":"2019","author":"Cenini","year":"2019","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pneurobio.2006.11.001","article-title":"The corticostriatal pathway in Huntington's disease","volume":"81","author":"Cepeda","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/(SICI)1097-4547(19991001)58:1<>3.0.CO;2-K","article-title":"Caspase and calpain substrates: roles in synaptic plasticity and cell death","volume":"58","author":"Chan","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nature715","article-title":"Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits","volume":"415","author":"Chatterton","year":"2002","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"E6983","DOI":"10.1073\/pnas.1517045112","article-title":"PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41586-024-07742-0","article-title":"Molecular mechanism of ligand gating and opening of NMDA receptor","volume":"632","author":"Chou","year":"2024","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1750-1326-2-22","article-title":"The Alzheimer's disease beta-secretase enzyme, BACE1","volume":"2","author":"Cole","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1113\/JP280879","article-title":"GluN3A NMDA receptor subunits: more enigmatic than ever?","volume":"600","author":"Crawley","year":"2022","journal-title":"J. Physiol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e17187","DOI":"10.1371\/journal.pone.0017187","article-title":"Astroglial inhibition of NF-\u03baB does not ameliorate disease onset and progression in a mouse model for amyotrophic lateral sclerosis (ALS)","volume":"6","author":"Crosio","year":"2011","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","article-title":"NMDA receptor subunits: diversity, development and disease","volume":"11","author":"Cull-Candy","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0891-0618(96)00148-2","article-title":"Nitric oxide neurotoxicity","volume":"10","author":"Dawson","year":"1996","journal-title":"J. Chem. Neuroanat."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1073\/pnas.88.14.6368","article-title":"Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures","volume":"88","author":"Dawson","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3109\/17482968.2010.498521","article-title":"A randomized, placebo-controlled trial of memantine for functional disability in amyotrophic lateral sclerosis","volume":"11","author":"de Carvalho","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/ijms19123800","article-title":"Flux-independent NMDAR signaling: molecular mediators, cellular functions, and complexities","volume":"19","author":"de Oca","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.bbrc.2020.06.123","article-title":"Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases","volume":"529","author":"Dembitsky","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1174738","DOI":"10.3389\/fnmol.2023.1174738","article-title":"N-methyl-D-aspartate receptor hypofunction as a potential contributor to the progression and manifestation of many neurological disorders","volume":"16","author":"Dong","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1523\/JNEUROSCI.21-15-05546.2001","article-title":"Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane","volume":"21","author":"Dunah","year":"2001","journal-title":"J. Neurosci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S0026-895X(24)23206-5","article-title":"Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease","volume":"57","author":"Dunah","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mam.2004.09.004","article-title":"Nitric oxide and neurological disorders","volume":"26","author":"Duncan","year":"2005","journal-title":"Mol. Asp. Med."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/brain\/awz065","article-title":"Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration","volume":"142","author":"Durante","year":"2019","journal-title":"Brain"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/ph17050639","article-title":"NMDA receptor antagonists: emerging insights into molecular mechanisms and clinical applications in neurological disorders","volume":"17","author":"Egunlusi","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"8231","DOI":"10.1002\/alz.14125","article-title":"Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer's disease patients","volume":"20","author":"Escamilla","year":"2024","journal-title":"Alzheimers Dement."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/cns.12095","article-title":"Amyloid \u03b2, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track?","volume":"19","author":"Esposito","year":"2013","journal-title":"CNS Neurosci. Ther."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"10928","DOI":"10.1523\/JNEUROSCI.2491-09.2009","article-title":"Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease","volume":"29","author":"Fan","year":"2009","journal-title":"J. Neurosci."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.pneurobio.2006.11.003","article-title":"N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease","volume":"81","author":"Fan","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"ref48","article-title":"Frontiers in neuroscience NMDA Receptors and Huntington\u2019s Disease","volume-title":"Biology of the NMDA receptor","author":"Fernandes","year":"2009"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.neuron.2014.01.013","article-title":"Microglia induce motor neuron death via the classical NF-\u03baB pathway in amyotrophic lateral sclerosis","volume":"81","author":"Frakes","year":"2014","journal-title":"Neuron"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1523\/JNEUROSCI.5053-06.2007","article-title":"Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells","volume":"27","author":"Garzon","year":"2007","journal-title":"J. Neurosci."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","article-title":"Lipid peroxidation in cell death","volume":"482","author":"Gaschler","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuroscience.2018.02.017","article-title":"Nitric oxide and mitochondrial function in neurological diseases","volume":"376","author":"Ghasemi","year":"2018","journal-title":"Neuroscience"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1146\/annurev-pharmtox-032320-015420","article-title":"Novel therapeutic approach for excitatory\/inhibitory imbalance in neurodevelopmental and neurodegenerative diseases","volume":"61","author":"Ghatak","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.mcn.2011.05.001","article-title":"Mechanisms underlying NMDA receptor synaptic\/extrasynaptic distribution and function","volume":"48","author":"Gladding","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"9686","DOI":"10.1523\/JNEUROSCI.1173-17.2017","article-title":"Memantine and ketamine differentially Alter NMDA receptor desensitization","volume":"37","author":"Glasgow","year":"2017","journal-title":"J. Neurosci."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.coph.2005.11.001","article-title":"Glutamate-based therapeutic approaches: NR2B receptor antagonists","volume":"6","author":"Gogas","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1001\/archneur.1991.00530210109030","article-title":"N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease","volume":"48","author":"Greenamyre","year":"1991","journal-title":"Arch. Neurol."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.neuron.2008.09.002","article-title":"From synapse to nucleus: calcium-dependent gene transcription in the control of synapse development and function","volume":"59","author":"Greer","year":"2008","journal-title":"Neuron"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neuroscience.2008.05.029","article-title":"Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives","volume":"158","author":"Groc","year":"2009","journal-title":"Neuroscience"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1085\/jgp.201812032","article-title":"Structure, function, and allosteric modulation of NMDA receptors","volume":"150","author":"Hansen","year":"2018","journal-title":"J. Gen. Physiol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.celrep.2019.12.030","article-title":"GluN2A NMDA receptor enhancement improves brain oscillations, synchrony, and cognitive functions in Dravet syndrome and Alzheimer's disease models","volume":"30","author":"Hanson","year":"2020","journal-title":"Cell Rep."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0166-2236(02)00040-1","article-title":"The yin and Yang of NMDA receptor signalling","volume":"26","author":"Hardingham","year":"2003","journal-title":"Trends Neurosci."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson's disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/mus.10186","article-title":"Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis","volume":"26","author":"Heath","year":"2002","journal-title":"Muscle Nerve"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.01.004","article-title":"Influence of the NR3A subunit on NMDA receptor functions","volume":"91","author":"Henson","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1523\/JNEUROSCI.5209-10.2011","article-title":"PKC epsilon activation prevents synaptic loss, Abeta elevation, and cognitive deficits in Alzheimer's disease transgenic mice","volume":"31","author":"Hongpaisan","year":"2011","journal-title":"J. Neurosci."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1054006","DOI":"10.3389\/fphar.2022.1054006","article-title":"New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1113\/jphysiol.2005.095554","article-title":"Functional NR2B- and NR2D-containing NMDA receptor channels in rat substantia nigra dopaminergic neurones","volume":"569","author":"Jones","year":"2005","journal-title":"J. Physiol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3988\/jcn.2007.3.4.181","article-title":"Oral administration of memantine prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"3","author":"Joo","year":"2007","journal-title":"J. Clin. Neurol."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/ijms22083875","article-title":"The links between ALS and NF-\u03baB","volume":"22","author":"K\u00e4llstig","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1073\/pnas.1219605110","article-title":"Metabotropic NMDA receptor function is required for \u03b2-amyloid-induced synaptic depression","volume":"110","author":"Kessels","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/ijms22168363","article-title":"New avenues for the treatment of Huntington's disease","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/jcp.22609","article-title":"Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics","volume":"226","author":"Kim","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jalz.2018.05.017","article-title":"N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-\u03b2 oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease","volume":"14","author":"Kodis","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00441-006-0273-6","article-title":"NMDA receptor function: subunit composition versus spatial distribution","volume":"326","author":"K\u00f6hr","year":"2006","journal-title":"Cell Tissue Res."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fmolb.2018.00008","article-title":"Focus on the role of D-serine and D-amino acid oxidase in amyotrophic lateral sclerosis\/motor neuron disease (ALS)","volume":"5","author":"Kondori","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/AN20130017","article-title":"Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex","volume":"5","author":"Kulijewicz-Nawrot","year":"2013","journal-title":"ASN Neuro"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.1523\/JNEUROSCI.15-07-05297.1995","article-title":"NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum","volume":"15","author":"Landwehrmeyer","year":"1995","journal-title":"J. Neurosci."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers Arch."},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.neurobiolaging.2003.04.003","article-title":"Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease","volume":"24","author":"Li","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1113\/jphysiol.2011.215566","article-title":"SAP97 directs NMDA receptor spine targeting and synaptic plasticity","volume":"589","author":"Li","year":"2011","journal-title":"J. Physiol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/neur.1996.0042","article-title":"Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration","volume":"5","author":"Liang","year":"1996","journal-title":"Neurodegeneration"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2174\/156802606777057599","article-title":"Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia","volume":"6","author":"Lindsley","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"ref94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1113\/jphysiol.2012.235119","article-title":"The developmental stages of synaptic plasticity","volume":"592","author":"Lohmann","year":"2014","journal-title":"J. Physiol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/JAD-2012-120409","article-title":"4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures","volume":"32","author":"Lovell","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1101\/cshperspect.a005710","article-title":"NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD)","volume":"4","author":"L\u00fcscher","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/cells8020184","article-title":"Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release","volume":"8","author":"Mahmoud","year":"2019","journal-title":"Cells"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/JAD-2007-11208","article-title":"Nitric oxide and nitroxidative stress in Alzheimer's disease","volume":"11","author":"Malinski","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/nm.3246","article-title":"Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models","volume":"19","author":"Marco","year":"2013","journal-title":"Nat. Med."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fncel.2015.00245","article-title":"NMDA receptor GluN2A\/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients","volume":"9","author":"Mellone","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.nbd.2018.09.021","article-title":"NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology","volume":"121","author":"Mellone","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref103","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41583-020-0344-9","article-title":"Diversity and function of corticopetal and corticofugal GABAergic projection neurons","volume":"21","author":"Melzer","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/s0197-0186(01)00125-5","article-title":"Mitochondrial involvement in amyotrophic lateral sclerosis","volume":"40","author":"Menzies","year":"2002","journal-title":"Neurochem. Int."},{"key":"ref105","first-page":"273","article-title":"Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study","volume":"22","author":"Merello","year":"1999","journal-title":"Clin. Neuropharmacol."},{"key":"ref106","first-page":"480","article-title":"Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease","volume":"17","author":"Metman","year":"1998","journal-title":"Nervenheilkunde"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/JAD-221063","article-title":"Vesicular glutamate transporter changes in the cortical default mode network during the clinical and pathological progression of Alzheimer's disease","volume":"94","author":"Mi","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"ref108","first-page":"Cd001447","article-title":"Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND)","volume":"3","author":"Miller","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1073\/pnas.0914128107","article-title":"Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase","volume":"107","author":"Mitchell","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0896-6273(94)90210-0","article-title":"Developmental and regional expression in the rat brain and functional properties of four NMDA receptors","volume":"12","author":"Monyer","year":"1994","journal-title":"Neuron"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.neuropharm.2013.04.014","article-title":"NMDA receptors and memory encoding","volume":"74","author":"Morris","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.coph.2005.12.002","article-title":"Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists","volume":"6","author":"Muir","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/jnr.24029","article-title":"Astroglial glutamate transporters in the brain: regulating neurotransmitter homeostasis and synaptic transmission","volume":"95","author":"Murphy-Royal","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"ref116","doi-asserted-by":"publisher","first-page":"20130145","DOI":"10.1098\/rstb.2013.0145","article-title":"GluA1 trafficking and metabotropic NMDA: addressing results from other laboratories inconsistent with ours","volume":"369","author":"Nabavi","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"107426","DOI":"10.1016\/j.pharmthera.2019.107426","article-title":"The origin of NMDA receptor hypofunction in schizophrenia","volume":"205","author":"Nakazawa","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"121814","DOI":"10.1016\/j.lfs.2023.121814","article-title":"Molecular mechanisms of ischemia and glutamate excitotoxicity","volume":"328","author":"Neves","year":"2023","journal-title":"Life Sci."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1523\/JNEUROSCI.16-07-02157.1996","article-title":"Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases","volume":"16","author":"Niethammer","year":"1996","journal-title":"J. Neurosci."},{"key":"ref120","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.parkreldis.2006.08.005","article-title":"A pilot study of the clinical efficacy and safety of memantine for Huntington's disease","volume":"13","author":"Ondo","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"109871","DOI":"10.1016\/j.neuropharm.2024.109871","article-title":"Dopamine-loaded chitosan-coated solid lipid nanoparticles as a promise nanocarriers to the CNS","volume":"249","author":"Ortega Mart\u00ednez","year":"2024","journal-title":"Neuropharmacology"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"14182","DOI":"10.1523\/JNEUROSCI.2149-10.2010","article-title":"Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition","volume":"30","author":"Paill\u00e9","year":"2010","journal-title":"J. Neurosci."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/jnc.15255","article-title":"Cellular and physiological functions of C9ORF72 and implications for ALS\/FTD","volume":"157","author":"Pang","year":"2021","journal-title":"J. Neurochem."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/j.1460-9568.2011.07628.x","article-title":"Molecular basis of NMDA receptor functional diversity","volume":"33","author":"Paoletti","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410390505","article-title":"Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys","volume":"39","author":"Papa","year":"1996","journal-title":"Ann. Neurol."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1523\/JNEUROSCI.5019-04.2005","article-title":"Nuclear Ca2+ and the cAMP response element-binding protein family mediate a late phase of activity-dependent neuroprotection","volume":"25","author":"Papadia","year":"2005","journal-title":"J. Neurosci."},{"key":"ref128","doi-asserted-by":"publisher","first-page":"109019","DOI":"10.1016\/j.neuropharm.2022.109019","article-title":"Ion flux-independent NMDA receptor signaling","volume":"210","author":"Park","year":"2022","journal-title":"Neuropharmacology"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnsyn.2014.00010","article-title":"The role of D-serine and glycine as co-agonists of NMDA receptors in motor neuron degeneration and amyotrophic lateral sclerosis (ALS)","volume":"6","author":"Paul","year":"2014","journal-title":"Front. Synaptic Neurosci."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.neurobiolaging.2013.09.005","article-title":"Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine","volume":"35","author":"Paul","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuroscience.2010.01.022","article-title":"Organization of NMDA receptors at extrasynaptic locations","volume":"167","author":"Petralia","year":"2010","journal-title":"Neuroscience"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/978-3-7091-0932-8_24","article-title":"Synaptic dysfunction in Parkinson's disease","volume":"970","author":"Picconi","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson's disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/archneurol.2008.588","article-title":"PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia","volume":"66","author":"Qin","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/ijms25094757","article-title":"Dual role of NMDAR containing NR2A and NR2B subunits in Alzheimer's disease","volume":"25","author":"Ra\u00efch","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"ref137","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuroscience.2011.08.052","article-title":"Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function","volume":"198","author":"Raymond","year":"2011","journal-title":"Neuroscience"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1111\/j.1742-4658.2006.05352.x","article-title":"Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease","volume":"273","author":"Raynaud","year":"2006","journal-title":"FEBS J."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","article-title":"Lipid peroxidation and neurodegenerative disease","volume":"51","author":"Reed","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1023\/A:1025682611389","article-title":"Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases","volume":"28","author":"Rego","year":"2003","journal-title":"Neurochem. Res."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0197-0186(99)00150-3","article-title":"Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes","volume":"36","author":"Robinson","year":"2000","journal-title":"Neurochem. Int."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1002\/ana.410440726","article-title":"Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection","volume":"44","author":"Rodriguez","year":"1998","journal-title":"Ann. Neurol."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/hipo.22607","article-title":"Down-regulation of glutamatergic terminals (VGLUT1) driven by a\u03b2 in Alzheimer's disease","volume":"26","author":"Rodriguez-Perdigon","year":"2016","journal-title":"Hippocampus"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1016\/j.neurobiolaging.2015.04.014","article-title":"CREB expression mediates amyloid \u03b2-induced basal BDNF downregulation","volume":"36","author":"Rosa","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(87)90177-9","article-title":"Excitotoxity and the NMDA receptor","volume":"10","author":"Rothman","year":"1987","journal-title":"Trends Neurosci."},{"key":"ref147","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0166-2236(95)93869-y","article-title":"Excitotoxicity and the NMDA receptor - still lethal after eight years","volume":"18","author":"Rothman","year":"1995","journal-title":"Trends Neurosci."},{"key":"ref148","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.410280106","article-title":"Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis","volume":"28","author":"Rothstein","year":"1990","journal-title":"Ann. Neurol."},{"key":"ref149","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ana.410380114","article-title":"Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis","volume":"38","author":"Rothstein","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref150","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/1073858411435129","article-title":"Diversity in NMDA receptor composition: many regulators, many consequences","volume":"19","author":"Sanz-Clemente","year":"2013","journal-title":"Neuroscientist"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1073\/pnas.1114639109","article-title":"D-amino acid oxidase controls motoneuron degeneration through D-serine","volume":"109","author":"Sasabe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jpsychires.2016.02.023","article-title":"Exercise as a treatment for depression: a meta-analysis adjusting for publication bias","volume":"77","author":"Schuch","year":"2016","journal-title":"J. Psychiatr. Res."},{"key":"ref154","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1523\/JNEUROSCI.5274-12.2013","article-title":"Amyloid-\u03b21-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1","volume":"33","author":"Scimemi","year":"2013","journal-title":"J. Neurosci."},{"key":"ref155","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.drudis.2014.02.006","article-title":"Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease","volume":"19","author":"Sepers","year":"2014","journal-title":"Drug Discov. Today"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","article-title":"Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons","volume":"24","author":"Shi","year":"2018","journal-title":"Nat. Med."},{"key":"ref157","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/molecules24081583","article-title":"Oxidative stress: a key modulator in neurodegenerative diseases","volume":"24","author":"Singh","year":"2019","journal-title":"Molecules"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/sj.emboj.7600555","article-title":"Positive and negative regulation of EAAT2 by NF-kappaB: a role for N-myc in TNFalpha-controlled repression","volume":"24","author":"Sitcheran","year":"2005","journal-title":"EMBO J."},{"key":"ref159","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fnmol.2016.00118","article-title":"Neuronal gene targets of NF-\u03baB and their dysregulation in Alzheimer's disease","volume":"9","author":"Snow","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref160","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.bbadis.2012.11.013","article-title":"Role of the N-methyl-d-aspartate receptors complex in amyotrophic lateral sclerosis","volume":"1832","author":"Spalloni","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1523\/JNEUROSCI.3544-11.2011","article-title":"Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection","volume":"31","author":"Stark","year":"2011","journal-title":"J. Neurosci."},{"key":"ref162","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1073\/pnas.0136555100","article-title":"Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2)","volume":"100","author":"Su","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1460-9568.2010.07298.x","article-title":"Functional heterogeneity of NMDA receptors in rat substantia nigra pars compacta and reticulata neurones","volume":"32","author":"Su\u00e1rez","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"ref164","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/mds.25095","article-title":"Neuronal vulnerability, pathogenesis, and Parkinson's disease","volume":"28","author":"Sulzer","year":"2013","journal-title":"Mov. Disord."},{"key":"ref165","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/ijms23168972","article-title":"The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer's disease","volume":"23","author":"Sun","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref166","doi-asserted-by":"publisher","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95*","volume":"276","author":"Sun","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref167","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1194\/jlr.R300016-JLR200","article-title":"Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases","volume":"45","author":"Sun","year":"2004","journal-title":"J. Lipid Res."},{"key":"ref168","doi-asserted-by":"publisher","first-page":"15971","DOI":"10.1523\/JNEUROSCI.1702-15.2015","article-title":"NMDA receptors containing the GluN2D subunit control neuronal function in the subthalamic nucleus","volume":"35","author":"Swanger","year":"2015","journal-title":"J. Neurosci."},{"key":"ref169","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5115\/acb.2016.49.1.1","article-title":"The association between PGC-1\u03b1 and Alzheimer's disease","volume":"49","author":"Sweeney","year":"2016","journal-title":"Anat. Cell Biol."},{"key":"ref170","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ceca.2010.01.003","article-title":"Calcium, ischemia and excitotoxicity","volume":"47","author":"Szydlowska","year":"2010","journal-title":"Cell Calcium"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"e65350","DOI":"10.1371\/journal.pone.0065350","article-title":"NMDA-receptor activation but not ion flux is required for amyloid-beta induced synaptic depression","volume":"8","author":"Tamburri","year":"2013","journal-title":"PLoS One"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.4103\/1673-5374.285006","article-title":"Neuroprotective effects of ZL006 in a\u03b2(1-42)-treated neuronal cells","volume":"15","author":"Tao","year":"2020","journal-title":"Neural Regen. Res."},{"key":"ref173","doi-asserted-by":"publisher","first-page":"1187411","DOI":"10.3389\/fphar.2023.1187411","article-title":"Bryostatin-1: a promising compound for neurological disorders","volume":"14","author":"Tian","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref174","doi-asserted-by":"publisher","first-page":"101567","DOI":"10.1016\/j.redox.2020.101567","article-title":"The role of nitric oxide in brain disorders: autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders","volume":"34","author":"Tripathi","year":"2020","journal-title":"Redox Biol."},{"key":"ref175","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1523\/JNEUROSCI.1871-20.2020","article-title":"\u0391-Synuclein oligomers induce glutamate release from astrocytes and excessive Extrasynaptic NMDAR activity in neurons, thus contributing to synapse loss","volume":"41","author":"Trudler","year":"2021","journal-title":"J. Neurosci."},{"key":"ref176","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00424-014-1630-z","article-title":"The differential contribution of GluN1 and GluN2 to the gating operation of the NMDA receptor channel","volume":"467","author":"Tu","year":"2015","journal-title":"Pflugers Arch."},{"key":"ref177","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s11030-023-10656-0","article-title":"GluN2B subunit selective N-methyl-D-aspartate receptor ligands: democratizing recent progress to assist the development of novel neurotherapeutics","volume":"28","author":"Ugale","year":"2024","journal-title":"Mol. Divers."},{"key":"ref178","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2013.06.036","article-title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer a\u03b2 oligomer bound to cellular prion protein","volume":"79","author":"Um","year":"2013","journal-title":"Neuron"},{"key":"ref179","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.3178","article-title":"Alzheimer amyloid-\u03b2 oligomer bound to postsynaptic prion protein activates Fyn to impair neurons","volume":"15","author":"Um","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref180","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","article-title":"The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis","volume":"1762","author":"Van Den Bosch","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref181","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.nbd.2019.04.010","article-title":"Excitatory-inhibitory imbalance in Alzheimer's disease and therapeutic significance","volume":"127","author":"Vico Varela","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref182","doi-asserted-by":"publisher","first-page":"S191","DOI":"10.33549\/physiolres.932678","article-title":"Structure, function, and pharmacology of NMDA receptor channels","volume":"63","author":"Vyklicky","year":"2014","journal-title":"Physiol. Res."},{"key":"ref183","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"ref184","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of glutamate and NMDA receptors in Alzheimer's disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"ref185","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1007\/s12035-016-0008-y","article-title":"DAPK1 signaling pathways in stroke: from mechanisms to therapies","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref186","doi-asserted-by":"publisher","first-page":"3370","DOI":"10.1523\/JNEUROSCI.1633-03.2004","article-title":"Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5","volume":"24","author":"Wang","year":"2004","journal-title":"J. Neurosci."},{"key":"ref187","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1111\/j.1460-9568.2005.04431.x","article-title":"Memantine prolongs survival in an amyotrophic lateral sclerosis mouse model","volume":"22","author":"Wang","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"ref188","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s12264-013-1383-2","article-title":"Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-\u03b2","volume":"29","author":"Wang","year":"2013","journal-title":"Neurosci. Bull."},{"key":"ref189","doi-asserted-by":"publisher","first-page":"21379","DOI":"10.1074\/jbc.M109.018911","article-title":"PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons","volume":"284","author":"Wareski","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref190","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/cne.903430402","article-title":"Distinct spatiotemporal expressions of five NMDA receptor channel subunit mRNAs in the cerebellum","volume":"343","author":"Watanabe","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"ref191","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/jamaneurol.2014.3953","article-title":"Modulation of GluN3A expression in Huntington disease: a new n-methyl-D-aspartate receptor-based therapeutic approach?","volume":"72","author":"Wesseling","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref192","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.neuropharm.2013.01.016","article-title":"Influence of GluN2 subunit identity on NMDA receptor function","volume":"74","author":"Wyllie","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref193","doi-asserted-by":"publisher","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J. Neurosci."},{"key":"ref194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.02.002","article-title":"Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease","volume":"97","author":"Xu","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"ref195","doi-asserted-by":"publisher","first-page":"117150","DOI":"10.1016\/j.bmc.2022.117150","article-title":"Design and synthesis of 6-methylpyridin-2-one derivatives as novel and potent GluN2A positive allosteric modulators for the treatment of cognitive impairment","volume":"79","author":"Yukawa","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"ref196","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuropharm.2015.01.007","article-title":"Dopamine depletion of the striatum causes a cell-type specific reorganization of GluN2B- and GluN2D-containing NMDA receptors","volume":"92","author":"Zhang","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref197","doi-asserted-by":"publisher","first-page":"1253273","DOI":"10.3389\/fimmu.2023.1253273","article-title":"Levodopa-induced dyskinesia: interplay between the N-methyl-D-aspartic acid receptor and neuroinflammation","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"ref198","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1038\/s41598-020-64738-2","article-title":"Protopanaxadiol ginsenoside Rd protects against NMDA receptor-mediated excitotoxicity by attenuating calcineurin-regulated DAPK1 activity","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1604378\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T05:33:17Z","timestamp":1753335197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1604378\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":198,"alternative-id":["10.3389\/fnagi.2025.1604378"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1604378","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"article-number":"1604378"}}